coxsackievirus a21
Biologicalexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00235482)
Timeline
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- coxsackievirus a21
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01636882 | Phase 2 | Jun 1, 2012 | Viralytics |
| NCT01227551 | Phase 2 | Oct 1, 2011 | Viralytics |
| NCT00832559 | Phase 1 | Jan 1, 2009 | Australian National University, Monash University, Viralytics |
| NCT00438009 | Phase 1 | Feb 1, 2007 | Viralytics |
| NCT00235482 | Phase 1 | Aug 1, 2005 | Viralytics |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Viralytics | For profit | 5 | 5 | 2 | 2005 |
| Australian National University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Monash University | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1